Mack Roach III, MD

Mack Roach III, MD

Mack Roach III, MD

Professor
 of Radiation Oncology and Urology

Education

BS, 1975, Morehouse College, Atlanta, GA, Physics
MD, 1979, Stanford University, Stanford, CA, Medicine
Internship & Residency, 1981, Martin Luther King Jr. General Hospital, Los Angeles, CA
Fellowship, 1983, University of California, San Francisco, Hematology-Oncology
Chief Resident, 1984, Highland General Hospital, Oakland, CA
Residency, 1987, Stanford University, Stanford, CA, Radiation Oncology

Biography

Mack Roach III, MD, is a Professor of Radiation Oncology, Medical Oncology and Urology, at the University of California, San Francisco. Roach earned his MD from Stanford University School of Medicine. His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors. Over the last 10 years, his research efforts have been directed at defining optimal imaging modalities, as well as criteria for defining target volumes and improved treatment techniques. Roach chaired one of the most important large prospective randomized trials comparing different strategies for locally advanced prostate cancer. He has gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning recently published by the American College of Radiology. Roach is a member of several professional societies including the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, Radiation Therapy Oncology Group, the NCI IMRT Working Group and American Joint Commission for Cancer (AJCC) Staging (GU), the American Cancer Society (ACS) Task for Cancer Screening Guidelines (Prostate cancer) and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials).

Clinical Interests

Roach's clinical interests include the management of prostate cancer and other solid tumors with three dimensional (3D) conformal radiation therapy, Intensity Modulated Radiation Therapy (IMRT) technologies. 

Research Interests

Roach's major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) as a major component of combined modality management of prostate cancer and other solid tumors. Over the last 12 years his research efforts have been directed at defining optimal imaging modalities, criteria for target definitions, development of improved treatment techniques, as well as the prediction of complication probabilities. This work has found expression in the Clinical Trials Cooperative Group Mechanism. He chaired a large prospective randomized trial comparing different strategies for locally advanced prostate cancer. He has gained recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning, recently published by the American College of Radiology. He has begun to pioneer intensity modulated radiotherapy (IMRT), in combination with Online Portal Imaging, and improved dose calculation algorithms that should allow UCSF Radiation Oncology to provide leadership in the field of radiotherapy for many years to come. Roach is considered a foremost authority in disparities in outcomes from cancer treatment in underserved populations. A recently funded NIH U-56 cooperative planning grant with San Francisco State University should allow both institutions to build a program to effectively address this area in years to come.

Patient Contact

For appointments, please contact:

415.476-4616  (Phone)
 

1825 4th Street
6th floor, Baker Precision Cancer Medicine Building
San Francisco, CA 94158

Academic Contact

415.353.7175 or 415.476.5228  (Phone)
415.353.9883  (Fax)

Department of Radiation Oncology,
Box 1708

San Francisco, CA 94143-1708

Send Email